Abstract
This chapter explores the pharmacological treatment of paraphilic sex offenders. The World Federation of Societies of Biological Psychiatry (WFSBP) established a task force to evaluate the evidence-based treatment of the paraphilic disorders for both adults and adolescents. The primary aim of WFSBP guidelines for the biological treatment of the paraphilias was to evaluate the role of pharmacological agents in the treatment and management of paraphilias with a focus on the treatment of adult males. These guidelines were intended for use in clinical practice by clinicians who diagnose and treat paraphilia, now known as paraphilic disorders. The term paraphilia denotes any intense and persistent sexual interest other than sexual interest in genital stimulation or preparatory fondling with phenotypically normal, physically mature, consenting human partners. A paraphilic disorder is a paraphilia that is currently causing distress or impairment to the individual or a paraphilia whose satisfaction has entailed personal harm, or risk of harm, to others. A paraphilia is a necessary but not a sufficient condition for having a paraphilic disorder, and a paraphilia by itself does not necessarily justify or require clinical intervention.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
